Category: Consumer goods
Quick infos Headquarters: California, United States Trade prices Volume: 13.8M Market Cap: 644.7M Prev closed: Open: 9.06 High: 9.72 Low: 8.82 52 week low: 7.04 52 week high: 14.3 Dividends: No Dividends Next ER: May 16, 2023
Company Profile Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology.
Earnings History Date EPS / Forecast Revenue / Forecast May 16, 2023 March 24, 2023 - / -0.6224- / -November 15, 2022 - / -0.6672- / -November 3, 2022 -0.65 / -0.6428- / -August 10, 2022 - / -0.6998- / -view more
Historical Data Date Price Open High Low Vol Change ER Aug 15, 2022 14.240 13.550 14.270
13.550
859.80K 2.67% Aug 12, 2022 13.870 13.440 13.960
13.320
973.70K 4.68% Aug 11, 2022 13.250 13.720 13.760
12.820
2.69M -2.72% Aug 10, 2022 13.620 13.020 13.940
13.010
2.08M 5.01% Aug 9, 2022 12.970 12.600 13.000
12.130
1.44M -0.38% Aug 8, 2022 13.020 13.060 13.470
12.810
1.22M 0.54% Aug 5, 2022 12.950 12.615 13.050
12.530
1.38M 0.78% Aug 4, 2022 12.850 12.350 12.990
12.225
1.22M 4.90% Aug 3, 2022 12.250 11.890 12.330
11.782
1.56M 3.99% Aug 2, 2022 11.780 11.220 11.810
11.200
760.15K 5.46% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:2015 Employees:118 News
Gossamer Bio (GOSS) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner finance.yahoo.com Mar 8, 2023 9:35 am Gossamer Bio's stock falls 64% on findings for Phase 2 study for hypertension drug finance.yahoo.com Mar 8, 2023 8:19 am
Analyst Downgrades Gossamer Bio As Merck's Sotatercept Might Overshadow Seralutinib's Success finance.yahoo.com Mar 7, 2023 3:37 pm
7 Top Short-Squeeze Candidates to Watch in February finance.yahoo.com Feb 1, 2023 4:25 pm Gossamer Bio's stock falls 64% on findings for Phase 2 study for hypertension drug marketwatch.com Dec 8, 2022 8:19 am CTRM, NIU and GOTU among premarket losers seekingalpha.com Dec 7, 2022 9:31 pm Gossamer Bio downgraded to Equal Weight at Barclays after PAH readout seekingalpha.com Dec 7, 2022 9:08 pm Gossamer Bio selloff is an overreaction - Piper Sandler seekingalpha.com Dec 7, 2022 1:03 am
Analyst Turns Bullish On Aerovate As Competitor Data Reinforce Lead Program Thesis finance.yahoo.com Dec 6, 2022 1:19 pm
Analyst Expects 'Somewhat Smaller Effect Size' From Gossamer Bio's Upcoming PAH Trial finance.yahoo.com Nov 17, 2022 2:37 pm
Gossamer Bio Announces Third Quarter 2022 Financial Results and Provides Business Update finance.yahoo.com Nov 3, 2022 4:01 pm Gossamer sheds 63% even as PAH candidate reaches main goal in Phase 2 trial seekingalpha.com Dec 6, 2022 9:09 pm Catalyst watch: Eyes on Zoom Video earnings, Best Buy call, Mobileye ratings, DWAC vote and Polestar's reveal seekingalpha.com Nov 19, 2022 4:00 am Gossamer Bio GAAP EPS of -$0.65 misses by $0.01 seekingalpha.com Nov 4, 2022 5:12 am Wedbush expects positive phase 2 data readout from Gossamer Bio, starts with outperform seekingalpha.com Sep 19, 2022 11:47 pm
With 62% ownership of the shares, Gossamer Bio, Inc. (NASDAQ:GOSS) is heavily dominated by institutional owners finance.yahoo.com Aug 29, 2022 8:11 am Gossamer Bio GAAP EPS of -$0.74 misses by $0.04 seekingalpha.com Aug 9, 2022 8:30 pm
2 Strong Buy Stocks That In-The-Know Bigwigs Are Pouring Money Into finance.yahoo.com Jul 21, 2022 6:21 pm These stocks are on the most crowded shorts list - watch out above seekingalpha.com Jul 20, 2022 12:15 am
Here's Why Gossamer Bio (GOSS) is a Great Momentum Stock to Buy finance.yahoo.com Jul 19, 2022 12:00 pm This company doesn't provide a dividend.
Key Persons Chairman : Chairperson: Faheem Hasnain CEO : Sheila Gujrathi M.D. CFO : Bryan Giraudo Talk about Gossamer Bio Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis
